IMUN

Immune Therapeutics (PK) Stock Price

0.0136
-0.0019 (-12.26%)
0.0136
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Immune Therapeutics Inc (PK) IMUN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0019 -12.26% 0.0136 14:01:38
Open Price Low Price High Price Close Price Previous Close
0.012 0.012 0.0155 0.0155
Bid Price Ask Price Spread News
0.0132 0.014 0.0008 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
36 1,741,124 $ 0.013145 $ 22,888 3,496,014 0.0045 - 0.0499
Last Trade Time Type Quantity Stock Price Currency
14:01:38 10,000 $ 0.0136 USD

Immune Therapeutics (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.32M 464.47M 7.99M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
22.48k $ - 0.00% - -

more financials information »

Immune Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMUN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.017450.017450.0114280.01499443,115,515-0.00385-22.06%
1 Month0.0260.0260.0114280.01742843,321,445-0.0124-47.69%
3 Months0.01660.04890.01120.02615623,766,107-0.003-18.07%
6 Months0.0148750.04990.01120.025862,505,488-0.00128-8.57%
1 Year0.00510.04990.00450.02044911,983,5390.0085166.67%
3 Years0.01790.0590.00270.01885251,195,800-0.0043-24.02%
5 Years0.1240.280.00270.0300456904,579-0.1104-89.03%

Immune Therapeutics (PK) Description

Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.